Comparing ELISA Systems for Osteopontin Levels in Cancer Patients
Author Information
Author(s): Vordermark Dirk, Said Harun M, Katzer Astrid, Kuhnt Thomas, Hänsgen Gabriele, Dunst Jürgen, Flentje Michael, Bache Matthias
Primary Institution: Dept. of Radiation Oncology, University of Würzburg, Germany
Hypothesis
The choice of ELISA system affects plasma osteopontin levels in patients with head and neck and cervix cancer.
Conclusion
Different ELISA systems yield varying plasma osteopontin levels, complicating comparisons across studies.
Supporting Evidence
- Median plasma OPN levels were significantly different between the two assays.
- The correlation between the results of different assays was significant.
- Plasma OPN levels in cervix cancer patients were comparable to those in head and neck cancer patients.
Takeaway
This study looked at blood tests for a cancer marker and found that different testing methods can give very different results.
Methodology
Plasma samples from cancer patients were analyzed using different ELISA systems to compare osteopontin levels.
Potential Biases
Variability in assay performance and sample handling may introduce bias.
Limitations
The study did not compare results from identical samples using different assays directly.
Participant Demographics
34 samples from head and neck cancer patients (10 males, 1 female) and 54 from cervix cancer patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website